Pricing

Log inSign up

Primmune Therapeutics

1 follower

‌

Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Their goal is to improve the response rate of patients to current and future immunotherapy medicines.

Industries

Biotechnology

Headquarters

San Diego, United States

Employees

1-10

Links

Org chart

Charles McDermott
Chairman, President & CEO

Charles McDermott

Collapse
Richard Daniels
Chief Operating Officer
Paulo Rangel
Chief Business Officer & Co-Founder
James Appleman
SVP, R&D & CSO Co-Founder, Director
Curtis Scribner
Chief Medical Officer
Scott Zook
Senior Vice President Global Manufacturing
Stephen E. Webber
VP, Medicinal Chemistry, & Co-Founder
Randy Adams
Senior Advisor Commercial Strategy

Board & advisors

Todd Harris
Director
Amir Nashat
Director
Andrew Rubinstein
Director
Isan Chen
Clinical Advisor
Ezra Cohen
Clinical Advisor
Sheldon Morris
Clinical Advisor
Elina Zuniga
Scientific Advisor
Jyoti Mayadev
Clinical Advisor
Tom Coll
Outside Counsel

Teams

+3

Leadership Team

6 members

+1

Clinical Advisors Team

4 members

Legal and Governance Team

3 members

Research and Development Team

3 members

Offices

Similar companies

Thermo Fisher Scientific

182 followers

Genentech

163 followers

Gilead Sciences

137 followers

Biogen

123 followers

Regeneron

105 followers

Illumina

73 followers

Vertex Pharmaceuticals

66 followers

Agilent Technologies

73 followers

Roivant Sciences

56 followers

Verily Life Sciences

38 followers

Myriad Genetics

37 followers

Explore companies